Veterinary Medicines

Chevipok

Authorised
  • Pigeonpox virus, strain NJ, Live
Download as PDF

Product identification

Medicine name:
Chevipok
Active substance:
  • Pigeonpox virus, strain NJ, Live
Target species:
  • Pigeon
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Pigeonpox virus, strain NJ, Live
    1000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for oral suspension
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pigeon
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01ED01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chevita Tierarzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chevita Tierarzneimittel GmbH
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11530.01.1
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/09/2024
Download

2612214-paren-20110708.pdf

English (PDF)
Published on: 9/09/2024
Download